Mind Control, Nazi Germany, and the CIA | Norman Ohler on the history of LSD

Quick Overview

LSD was synthesized by Albert Hofmann at Sandoz in 1938 while researching ergot alkaloids for pharmaceutical development, but its potent psychoactive effects were only discovered five years later in 1943, leading to its eventual use in military mind control programs like MK-ULTRA.

Key Points: LSD (Lysergsäurediethylamid) was first synthesized in 1938 by Albert Hofmann at Sandoz in Basel, Switzerland, while researching ergot alkaloids for pharmaceutical applications. Hofmann accidentally discovered LSD's psychoactive properties five years later in 1943, after which initial tests on mice showed no effect, but he later experienced the effects himself. The company Sandoz initially focused on developing LSD as a potential 'truth drug' for interrogating captured Polish resistance fighters during WWII, although it ultimately proved ineffective for this purpose. Following WWII, the US military became interested in LSD, leading to the creation of the CIA's MK-ULTRA program, which continued testing the compound. The speaker notes that his previous assertion that LSD was shelved after 1938 until 1943 might be wrong, suggesting Hofmann may have felt effects earlier, although initial mouse tests showed nothing. The speaker references the historical anecdote of Hofmann taking LSD, cycling home, and experiencing vivid hallucinations, which is a famous episode in the drug's history.

Context: The video features a speaker, Norman Ohler, discussing the historical origins of LSD (Lysergic acid diethylamide), tracing its synthesis back to the pharmaceutical company Sandoz in Basel, Switzerland, and its discoverer, chemist Albert Hofmann. The discussion connects this discovery to subsequent interest from military and intelligence agencies, particularly during and after World War II, framing LSD's early development in the context of wartime research and potential interrogation tools.

Detailed Analysis

The speaker explains that LSD was created in 1938 by Albert Hofmann at Sandoz in Basel, Switzerland, as part of research into ergot alkaloids for medicinal purposes, aiming to create compounds that could generate dyes or, later, medications. Hofmann synthesized LSD-25 but initially found no effect when testing it on mice, who showed no reaction. However, five years later, in 1943, Hofmann synthesized it again and experienced its potent psychoactive effects, famously cycling home while tripping. The initial goal was to develop LSD as a 'truth drug' to extract information from captured Polish resistance fighters, but it failed in this capacity as subjects would not talk under its influence. After World War II, the US military, particularly through the CIA's MK-ULTRA program, took over interest in LSD, continuing the research started by the Swiss, who were interested in its potential for mind control, contrasting with the German interest in developing a truth serum for interrogation.